T7	Subject 2 17	61-year-old man
T9	Effect 28 184	clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus (LE) cell preparation, and diffuse proliferative glomerulonephritis
T10	Treatment 195 228	26 months of procainamide therapy
T11	Age 2 13	61-year-old
T12	Gender 14 17	man
T13	Drug 208 220	procainamide
T14	Duration 195 204	26 months
T8	Adverse_event 18 27	developed
E1	Adverse_event:T8